-
Je něco špatně v tomto záznamu ?
The serum protease network-one key to understand complex regional pain syndrome pathophysiology
S. König, M. Bayer, V. Dimova, M. Herrnberger, F. Escolano-Lozano, J. Bednarik, E. Vlckova, H. Rittner, T. Schlereth, F. Birklein,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- angiotensin konvertující enzym krev MeSH
- bolest patofyziologie MeSH
- bradykinin farmakologie MeSH
- cytokiny krev MeSH
- diabetické neuropatie krev MeSH
- dospělí MeSH
- komplexní regionální syndromy bolesti krev patofyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- měření bolesti MeSH
- proteasy krev MeSH
- Sudeckův syndrom krev diagnóza MeSH
- zánět farmakoterapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Complex regional pain syndrome (CRPS) develops after fracture. The acute CRPS phenotype resembles exaggerated inflammation, which is explained by local and systemic activation of a proinflammatory network including peptides and cytokines. Epidemiologic data suggest that inactivation of the peptidase angiotensin-converting enzyme in patients treated for hypertension increases the odds to develop CRPS. This hint leads us to investigate the serum protease network activity in patients with CRPS vs respective controls. For this purpose, we developed a dabsyl-bradykinin (DBK)-based assay and used it to investigate patients with CRPS, as well as healthy and pain (painful diabetic neuropathy [dPNP]) controls. The major result is that the degradation of DBK to fragments 1-8 and 1-5 in healthy control and dPNP is shifted to higher values for DBK1-8 and lower values for DBK1-5 at 1 hour of incubation in patients with CRPS. Using this novel reporter peptide assay, we have been able to show that the resolving protease network for mediators such as BK might be different in patients with CRPS; having a look at the clinical signs, which resemble inflammation, this resolving protease network is probably less effective in CRPS.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023922
- 003
- CZ-PrNML
- 005
- 20201214131717.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/j.pain.0000000000001503 $2 doi
- 035 __
- $a (PubMed)30694931
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a König, Simone $u Core Unit Proteomics, Interdisciplinary Center for Clinical Research, Medical Faculty, University of Münster, Münster, Germany.
- 245 14
- $a The serum protease network-one key to understand complex regional pain syndrome pathophysiology / $c S. König, M. Bayer, V. Dimova, M. Herrnberger, F. Escolano-Lozano, J. Bednarik, E. Vlckova, H. Rittner, T. Schlereth, F. Birklein,
- 520 9_
- $a Complex regional pain syndrome (CRPS) develops after fracture. The acute CRPS phenotype resembles exaggerated inflammation, which is explained by local and systemic activation of a proinflammatory network including peptides and cytokines. Epidemiologic data suggest that inactivation of the peptidase angiotensin-converting enzyme in patients treated for hypertension increases the odds to develop CRPS. This hint leads us to investigate the serum protease network activity in patients with CRPS vs respective controls. For this purpose, we developed a dabsyl-bradykinin (DBK)-based assay and used it to investigate patients with CRPS, as well as healthy and pain (painful diabetic neuropathy [dPNP]) controls. The major result is that the degradation of DBK to fragments 1-8 and 1-5 in healthy control and dPNP is shifted to higher values for DBK1-8 and lower values for DBK1-5 at 1 hour of incubation in patients with CRPS. Using this novel reporter peptide assay, we have been able to show that the resolving protease network for mediators such as BK might be different in patients with CRPS; having a look at the clinical signs, which resemble inflammation, this resolving protease network is probably less effective in CRPS.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a bradykinin $x farmakologie $7 D001920
- 650 _2
- $a komplexní regionální syndromy bolesti $x krev $x patofyziologie $7 D020918
- 650 _2
- $a cytokiny $x krev $7 D016207
- 650 _2
- $a diabetické neuropatie $x krev $7 D003929
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x farmakoterapie $7 D007249
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a bolest $x patofyziologie $7 D010146
- 650 _2
- $a měření bolesti $7 D010147
- 650 _2
- $a proteasy $x krev $7 D010447
- 650 _2
- $a angiotensin konvertující enzym $x krev $7 D007703
- 650 _2
- $a Sudeckův syndrom $x krev $x diagnóza $7 D012019
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bayer, Malte $u Core Unit Proteomics, Interdisciplinary Center for Clinical Research, Medical Faculty, University of Münster, Münster, Germany.
- 700 1_
- $a Dimova, Violeta $u Department of Neurology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
- 700 1_
- $a Herrnberger, Myriam $u Department of Neurology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
- 700 1_
- $a Escolano-Lozano, Fabiola $u Department of Neurology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
- 700 1_
- $a Bednarik, Josef $u Central European Instutite of Technology and Medical Faculty, Masaryk University, Brno, Czech Republic. Department of Neurology, University Hospital Brno, Czech Republic.
- 700 1_
- $a Vlckova, Eva $u Central European Instutite of Technology and Medical Faculty, Masaryk University, Brno, Czech Republic. Department of Neurology, University Hospital Brno, Czech Republic.
- 700 1_
- $a Rittner, Heike $u Department of Anesthesiology, University of Würzburg, Würzburg, Germany.
- 700 1_
- $a Schlereth, Tanja $u Department of Neurology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany. Deutsche Klinik für Diagnostik, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany.
- 700 1_
- $a Birklein, Frank $u Department of Neurology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
- 773 0_
- $w MED00003677 $t Pain $x 1872-6623 $g Roč. 160, č. 6 (2019), s. 1402-1409
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30694931 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214131715 $b ABA008
- 999 __
- $a ok $b bmc $g 1596241 $s 1114598
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 160 $c 6 $d 1402-1409 $e - $i 1872-6623 $m Pain $n Pain $x MED00003677
- LZP __
- $a Pubmed-20201125